Clinical Trial Update: Randomized Pilot Study for the Treatment of Cutaneous Leiomyomas With Botulinum Toxin [Phase 2]

View source ↗

Summary

A randomized Phase 2 pilot trial evaluating botulinum toxin for treating cutaneous leiomyomas in hereditary leiomyomatosis and renal cell cancer has completed, …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous Leiomyomas
• Hereditary Leiomyomatosis and Renal Cell Cancer

Drugs mentioned

• OnabotulinumtoxinA (Botox) (Botulinum toxin type A)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Cutaneous Leiomyomas, Hereditary Leiomyomatosis and Renal Cell Cancer | Phase 2 | Status: COMPLETED | Results posted: 2015-01-06